Carcinoma, Non-Small-Cell Lung
Showing 1 - 25 of 574
NSCLC Trial in Worldwide (Repotrectinib, Crizotinib)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
-
Augusta, Georgia
- +40 more
Nov 29, 2023
Carcinoma, Non-small-Cell Lung Trial in New York, Fairfax (JNJ-86974680, Cetrelimab, Radiation Therapy)
Recruiting
- Carcinoma, Non-small-Cell Lung
- JNJ-86974680
- +2 more
-
New York, New York
- +1 more
Nov 8, 2023
NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Amivantamab
- +6 more
- (no location specified)
Nov 7, 2023
NSCLC, Tumor Metastasis Trial in Worldwide (LY3537982, Pembrolizumab, Placebo)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Neoplasm Metastasis
- LY3537982
- +5 more
-
Tucson, Arizona
- +217 more
Nov 1, 2023
QOL After SURGERY and ADJUVANT Treatment
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Quality of Life
- Questionnaires
-
Salamanca, SpainHospital Clínico Universitario
Oct 30, 2023
Lung Cancer, Lung Tumor Malignant, NSCLC Trial in Amsterdam (Neelde Based Confocal Laser Endomicroscopy, Conventional diagnostic
Recruiting
- Lung Cancer
- +3 more
- Neelde Based Confocal Laser Endomicroscopy
- Conventional diagnostic bronchoscopy
-
Amsterdam, NetherlandsAmsterdam University Medical Centers
Oct 6, 2023
NSCLC Trial (KB-GDT-01)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- KB-GDT-01
- (no location specified)
Sep 29, 2023
Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Self-administered survey at hospital
- +2 more
- (no location specified)
Oct 3, 2023
A Multicountry, Multicentre, Non-interventional, Retrospective
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Kuwait, KuwaitKuwait Cancer Control Center
Sep 13, 2023
NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Durvalumab
- +5 more
- (no location specified)
Aug 17, 2023
NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Cadonilimab
- +2 more
-
Wuhan, Hubei, ChinaQian Chu
Aug 18, 2023
Carcinoma, Squamous Cell of Head and Neck, NSCLC, Ovarian Tumors Trial (disitamab vedotin)
Not yet recruiting
- Carcinoma, Squamous Cell of Head and Neck
- +3 more
- disitamab vedotin
- (no location specified)
Aug 15, 2023
NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Sugemalimab and Chemotherapy
-
Changsha, ChinaHunan Cancer Hospital
Jul 7, 2023
Metabolic Response to Food in Advanced Lung Cancer
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Weight loss (%)
- (no location specified)
Jun 30, 2023
NSCLC Trial in Cologne (observational, non-interventional)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- observational, non-interventional
-
Cologne, GermanyUniversity Hospital Cologne
Jul 3, 2023
NSCLC Trial in Korea, Republic of, Malaysia, United States (Cetrelimab, Amivantamab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Fairfax, Virginia
- +3 more
Jun 16, 2023
NSCLC Trial in Chongqing (procedure, drug, radiation)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- bronchial artery interventional therapy
- +3 more
-
Chongqing, Chongqing, ChinaDaping Hospital, Third Military Medical University
May 27, 2023
NSCLC Trial in United States
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Daphne, Alabama
- +16 more
May 30, 2023
China With Non-Small-Cell Lung Cancer That is Unable to be
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- (no location specified)
May 16, 2023
Carcinoma, Renal Cell, NSCLC Trial in Belgium, France (Live Bacterial Product - Akkermansia muciniphila)
Recruiting
- Carcinoma, Renal Cell
- Carcinoma, Non-Small-Cell Lung
- Live Bacterial Product - Akkermansia muciniphila
-
Mons, Belgium
- +3 more
May 9, 2023
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- (no location specified)
Apr 21, 2023